Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with beta cell conservation in type 2 diabetes: the CODAM study

被引：0

作者：

van Greevenbroek, M. M. J. ^{[1
]}

Xin, Y. ^{[1
]}

Schuitemaker, T. ^{[1
]}

van derKallen, C. J. H. ^{[1
]}

Hertle, E. ^{[1
]}

Schalkwijk, C. G. ^{[1
]}

Stehouwer, C. D. A. ^{[1
]}

机构：

[1] Maastricht Univ, CARIM Sch Cardiovasc Dis, Internal Med, Maastricht, Netherlands

来源：

DIABETOLOGIA | 2016年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

142

引用

页码：S73 / S74

页数：2

共 50 条

[1] Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with late β-cell conservation in type 2 diabetes: The CODAM study
van Greevenbroek, Marleen
Xin, Ying
Schuitemaker, Thomas
van der Kallen, Carla
Hertle, Elisabeth
Schalkwijk, Casper
Stehouwer, Coen
MOLECULAR IMMUNOLOGY, 2017, 89 : 189 - 189
[2] The alternative pathway of complement activation is longitudinally associated with obesity: the CODAM study
Xin, Y.
Hertle, E.
van der Kallen, C.
Schalkwijk, C.
Stehouwer, C.
van Greevenbroek, M.
DIABETOLOGIA, 2016, 59 : S293 - S294
[3] The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes The CODAM study
Hertle, Elisabeth
Arts, Ilja C. W.
van der Kallen, Carla J. H.
Feskens, Edith J. M.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 446 - 457
[4] THE ALTERNATIVE COMPLEMENT PATHWAY IS ASSOCIATED WITH AN ADVERSE LIPID PROFILE: THE CODAM STUDY
Xin, Y.
van der Kallen, C. J. H.
Schalkwijk, C. G.
Stehouwer, C. D. A.
van Greevenbroek, M. M. J.
ATHEROSCLEROSIS, 2019, 287 : E30 - E31
[5] The alternative complement pathway is associated with an adverse lipid profile: the CODAM study
Jin, S.
Xin, Y.
van der Kallen, C.
Vogelzangs, N.
Arts, I.
Schalkwijk, C.
Stehouwer, C.
van Greevenbroek, M.
DIABETOLOGIA, 2019, 62 : S294 - S294
[6] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
Hertle, Elisabeth
Arts, Ilja C. W.
van der Kallen, Carla J. H.
Feskens, Edith J. M.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 228 - 228
[7] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
Hertle, E.
Arts, I. C. W.
van der Kallen, C. J. H.
Feskens, E. J. M.
Schalkwijk, C. G.
Stehouwer, C. D. A.
van Greevenbroek, M. M. J.
DIABETOLOGIA, 2014, 57 : S502 - S502
[8] PROTHROMBIN ACTIVATION BY FACTOR-B (BB) OF THE ALTERNATIVE PATHWAY OF COMPLEMENT
FAIR, DS
SUNDSMO, JS
SCHWARTZ, BS
EDGINGTON, TS
MULLEREBERHARD, HJ
THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 301 - 301
[9] Associations of the alternative pathway and classical pathway of complement activation with incident metabolic syndrome: The CODAM study
Xin, Ying
Hertle, Elisabeth
van der Kallen, Carla J. H.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
van Greevenbroek, Marleen M. J.
MOLECULAR IMMUNOLOGY, 2017, 89 : 190 - 190
[10] COMPLEMENT-DEPENDENT ACTIVATION OF PLASMINOGEN BY ACTIVATED FACTOR-B (BB) OF THE ALTERNATIVE PATHWAY OF COMPLEMENT
SUNDSMO, JS
WOOD, LM
THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 302 - 302

← 1 2 3 4 5 →